Thrivent Financial for Lutherans
NTUS

Thrivent Financial for Lutherans’s Natus Medical Inc NTUS Stock Holding History

Thrivent Financial for Lutherans’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-33,978
Closed -$1.11M – 2515
2022
Q2 		$1.11M Buy
33,978
+6,176
+22% +$195K ﹤0.01% 1650
2022
Q1 		$731K Buy
27,802
+9
+0% +$220 ﹤0.01% 2008
2021
Q4 		$660K Buy
27,793
+205
+0.7% +$5.06K ﹤0.01% 2081
2021
Q3 		$692K Sell
27,588
-271
-1% -$6.91K ﹤0.01% 2033
2021
Q2 		$724K Buy
27,859
+33
+0.1% +$898 ﹤0.01% 2031
2021
Q1 		$713K Sell
27,826
-207
-0.7% -$5.31K ﹤0.01% 2066
2020
Q4 		$562K Sell
28,033
-52
-0.2% -$1.02K ﹤0.01% 2084
2020
Q3 		$481K Sell
28,085
-208
-0.7% -$3.93K ﹤0.01% 1989
2020
Q2 		$617K Sell
28,293
-277
-1% -$6.34K ﹤0.01% 1810
2020
Q1 		$661K Buy
28,570
+1,426
+5% +$41.4K ﹤0.01% 1560
2019
Q4 		$895K Buy
27,144
+16
+0.1% +$513 ﹤0.01% 1556
2019
Q3 		$864K Buy
27,128
+629
+2% +$18.3K ﹤0.01% 1507
2019
Q2 		$681K Buy
26,499
+668
+3% +$17K ﹤0.01% 1638
2019
Q1 		$656K Buy
25,831
+1,915
+8% +$57.1K ﹤0.01% 1648
2018
Q4 		$814K Buy
23,916
+526
+2% +$17.1K ﹤0.01% 1292
2018
Q3 		$834K Buy
23,390
+431
+2% +$15.2K ﹤0.01% 1405
2018
Q2 		$792K Buy
22,959
+693
+3% +$24.3K ﹤0.01% 1410
2018
Q1 		$749K Buy
22,266
+2,361
+12% +$74.7K ﹤0.01% 1406
2017
Q4 		$760K Sell
19,905
-415
-2% -$16.6K ﹤0.01% 1416
2017
Q3 		$762K Buy
20,320
+340
+2% +$12K ﹤0.01% 1326
2017
Q2 		$745K Buy
19,980
+1,410
+8% +$50.9K ﹤0.01% 1278
2017
Q1 		$729K Buy
18,570
+930
+5% +$34.9K ﹤0.01% 1342
2016
Q4 		$614K Buy
17,640
+790
+5% +$31K ﹤0.01% 1406
2016
Q3 		$662K Buy
16,850
+750
+5% +$29.9K ﹤0.01% 1322
2016
Q2 		$609K Buy
16,100
+730
+5% +$24.4K ﹤0.01% 1329
2016
Q1 		$591K Buy
15,370
+1,150
+8% +$42.8K ﹤0.01% 1297
2015
Q4 		$683K Buy
14,220
+570
+4% +$26.4K ﹤0.01% 1216
2015
Q3 		$538K Buy
13,650
+850
+7% +$36.1K ﹤0.01% 1185
2015
Q2 		$545K Buy
12,800
+1,000
+8% +$39.9K ﹤0.01% 1066
2015
Q1 		$466K Hold
11,800
– – ﹤0.01% 1146
2014
Q4 		$425K Sell
11,800
-36,922
-76% -$1.24M ﹤0.01% 1201
2014
Q3 		$1.44M Buy
48,722
+1,150
+2% +$31.7K 0.01% 761
2014
Q2 		$1.2M Buy
47,572
+37,422
+369% +$925K 0.01% 831
2014
Q1 		$262K Buy
10,150
+50
+0.5% +$1.26K ﹤0.01% 1324
2013
Q4 		$227K Hold
10,100
– – ﹤0.01% 1422
2013
Q3 		$143K Sell
10,100
-1,000
-9% -$13.4K ﹤0.01% 1484
2013
Q2 		$152 Buy
+11,100
New +$151K ﹤0.01% 1491

Other funds holding NTUS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Thrivent Financial for Lutherans's NTUS Position: Q3 2022 in Review

Thrivent Financial for Lutherans sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 33,978 shares — an estimated $1.11M sold.

Thrivent Financial for Lutherans first reported a position in NTUS in Q2 2013 and held it in 37 quarters. The position peaked at $1.44M in Q3 2014. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

  • Thrivent Financial for Lutherans reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 33,978 Natus Medical Inc shares in Q3 2022, an estimated $1.11M.
  • Thrivent Financial for Lutherans first reported a position in Natus Medical Inc in Q2 2013 and held it in 37 quarters.
  • Thrivent Financial for Lutherans's Natus Medical Inc position peaked at $1.44M in Q3 2014.
  • 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on Thrivent Financial for Lutherans's 13F filing for Q3 2022, filed 14 Nov 2022.